TUSHAR MISRA - 16 Aug 2022 Form 4 Insider Report for Mersana Therapeutics, Inc. (MRSN)

Role
Chief Manufacturing Officer
Signature
/s/ Brigitte Eichner, as Attorney-in-Fact
Issuer symbol
MRSN
Transactions as of
16 Aug 2022
Net transactions value
-$13,341
Form type
4
Filing time
18 Aug 2022, 16:40:44 UTC
Previous filing
19 Jan 2022
Next filing
18 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRSN Common Stock Options Exercise $0 +6,250 $0.000000 6,250 16 Aug 2022 Direct F1
transaction MRSN Common Stock Sale $13,341 -1,879 -30% $7.10* 4,371 17 Aug 2022 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRSN Restricted stock unit Options Exercise $0 -6,250 -25% $0.000000 18,750 16 Aug 2022 Common Stock 6,250 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon the vesting of a portion of the restricted stock units ("RSUs") awarded to the Reporting Person on August 16, 2021.
F2 Represents the sale of shares of common stock to satisfy the Reporting Person's tax withholding obligations in connection with the service-based vesting and settlement of the RSUs.
F3 The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $7.10 to $7.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F4 Each RSU represents the contingent right to receive one share of common stock of the Issuer.
F5 The restricted stock units will vest in equal annual installments over the first four years after the vesting commencement date, August 16, 2021, subject to the Reporting Person's continued service to the Issuer on such vesting date.

Remarks:

Exhibit 24 - Power of Attorney